SevenBridge Financial Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.04M | Sell |
26,903
-362
| -1% | -$41.8K | 0.47% | 68 |
|
|
2025
Q4 | $2.93M | Sell |
27,265
-2,570
| -9% | -$241K | 0.47% | 72 |
|
|
2025
Q3 | $2.73M | Sell |
29,835
-7,596
| -20% | -$626K | 0.45% | 75 |
|
|
2025
Q2 | $3.01M | Sell |
37,431
-7,453
| -17% | -$592K | 0.53% | 64 |
|
|
2025
Q1 | $3.61M | Sell |
44,884
-11,644
| -21% | -$1.09M | 0.71% | 40 |
|
|
2024
Q4 | $4.89M | Sell |
56,528
-3,931
| -7% | -$405K | 0.93% | 30 |
|
|
2024
Q3 | $6.09M | Buy |
60,459
+4,042
| +7% | +$480K | 1.17% | 21 |
|
|
2024
Q2 | $6.27M | Buy |
56,417
+779
| +1% | +$100K | 1.39% | 16 |
|
|
2024
Q1 | $7.09M | Sell |
55,638
-2,030
| -4% | -$250K | 1.61% | 13 |
|
|
2023
Q4 | $6.29M | Buy |
57,668
+1,217
| +2% | +$126K | 1.49% | 13 |
|
|
2023
Q3 | $5.81M | Buy |
56,451
+491
| +0.9% | +$52.9K | 1.5% | 17 |
|
|
2023
Q2 | $6.46M | Sell |
55,960
-507
| -0.9% | -$57.6K | 1.67% | 13 |
|
|
2023
Q1 | $6.01M | Sell |
56,467
-13
| -0% | -$1.4K | 1.66% | 15 |
|
|
2022
Q4 | $6.27M | Sell |
56,480
-1,226
| -2% | -$125K | 1.83% | 12 |
|
|
2022
Q3 | $4.97M | Buy |
57,706
+10,337
| +22% | +$923K | 1.68% | 13 |
|
|
2022
Q2 | $4.32M | Sell |
47,369
-724
| -2% | -$64.2K | 1.75% | 12 |
|
|
2022
Q1 | $3.95M | Sell |
48,093
-3,336
| -6% | -$263K | 1.39% | 19 |
|
|
2021
Q4 | $3.94M | Buy |
51,429
+400
| +0.8% | +$31.9K | 1.19% | 23 |
|
|
2021
Q3 | $3.83M | Sell |
51,029
-227
| -0.4% | -$17.3K | 1.28% | 21 |
|
|
2021
Q2 | $3.99M | Sell |
51,256
-564
| -1% | -$42K | 1.3% | 20 |
|
|
2021
Q1 | $3.81M | Buy |
51,820
+2,080
| +4% | +$153K | 1.39% | 20 |
|
|
2020
Q4 | $3.88M | Buy |
49,740
+5,013
| +11% | +$383K | 1.52% | 18 |
|
|
2020
Q3 | $3.54M | Buy |
44,727
+1,013
| +2% | +$79.3K | 1.61% | 18 |
|
|
2020
Q2 | $3.23M | Buy |
43,714
+819
| +2% | +$61.7K | 1.6% | 18 |
|
|
2020
Q1 | $3.15M | Buy |
42,895
+2,943
| +7% | +$231K | 1.82% | 15 |
|
|
2019
Q4 | $3.47M | Sell |
39,952
-249
| -0.6% | -$20.5K | 0.91% | 23 |
|
|
2019
Q3 | $3.23M | Buy |
40,201
+725
| +2% | +$58.1K | 1.7% | 15 |
|
|
2019
Q2 | $3.16M | Sell |
39,476
-341
| -0.9% | -$26.1K | 1.13% | 24 |
|
|
2019
Q1 | $3.16M | Sell |
39,817
-39
| -0.1% | -$2.92K | 1.19% | 22 |
|
|
2018
Q4 | $2.91M | Sell |
39,856
-1,998
| -5% | -$141K | 1.78% | 15 |
|
|
2018
Q3 | $2.83M | Buy |
41,854
+478
| +1% | +$30.5K | 1.51% | 15 |
|
|
2018
Q2 | $2.4M | Buy |
41,376
+1,091
| +3% | +$61.5K | 1.33% | 17 |
|
|
2018
Q1 | $2.09M | Buy |
40,285
+451
| +1% | +$24.4K | 1.2% | 24 |
|
|
2017
Q4 | $2.14M | Buy |
39,834
+1,212
| +3% | +$67.2K | 1.18% | 22 |
|
|
2017
Q3 | $2.36M | Buy |
38,622
+1,301
| +3% | +$78.9K | 1.35% | 14 |
|
|
2017
Q2 | $2.3M | Buy |
37,321
+1,407
| +4% | +$85.6K | 1.4% | 13 |
|
|
2017
Q1 | $2.16M | Buy |
35,914
+20,376
| +131% | +$1.24M | 1.42% | 15 |
|
|
2016
Q4 | $927K | Hold |
15,538
| – | – | 0.67% | 45 |
|
|
2016
Q3 | $927K | Sell |
15,538
-607
| -4% | -$35.5K | 0.68% | 45 |
|
|
2016
Q2 | $888K | Buy |
+16,145
| New | +$859K | 0.62% | 53 |
|
Other funds holding MRK
VCM
VPM
SevenBridge Financial Group's MRK Position: Q1 2026 in Review
SevenBridge Financial Group reduced its Merck (MRK) stake by 1.3% in Q1 2026, selling an estimated $41.8K and leaving 26,903 shares worth $3.04M. The position accounts for 0.47% of the portfolio, ranked #68.
SevenBridge Financial Group first reported a position in MRK in Q2 2016 and has held it in 40 quarters since. The position peaked at $7.09M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- SevenBridge Financial Group held 26,903 shares of Merck worth $3.04M as of Q1 2026.
- SevenBridge Financial Group sold 362 Merck shares in Q1 2026, an estimated $41.8K.
- Merck made up 0.47% of SevenBridge Financial Group's portfolio in Q1 2026, its #68 holding.
- SevenBridge Financial Group first reported a position in Merck in Q2 2016 and has held it in 40 quarters since.
- SevenBridge Financial Group's Merck position peaked at $7.09M in Q1 2024.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on SevenBridge Financial Group's 13F filing for Q1 2026, filed 23 Apr 2026.